CIBC WORLD MARKET INC. - VALEANT PHARMACEUTICALS INTL ownership

VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 295 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2018. The put-call ratio across all filers is 2.21 and the average weighting 0.3%.

Quarter-by-quarter ownership
CIBC WORLD MARKET INC. ownership history of VALEANT PHARMACEUTICALS INTL
ValueSharesWeighting
Q2 2018$69,541,000
+29.5%
2,992,282
-11.3%
0.30%
+37.6%
Q1 2018$53,682,000
-24.4%
3,372,013
-1.3%
0.22%
-31.2%
Q4 2017$70,987,000
+33.7%
3,416,124
-7.8%
0.32%
+26.4%
Q3 2017$53,108,000
-17.9%
3,706,065
-0.9%
0.25%
-7.6%
Q2 2017$64,726,000
+60.4%
3,741,413
+2.3%
0.28%
+113.2%
Q1 2017$40,346,000
-24.3%
3,657,821
-0.3%
0.13%
-34.8%
Q4 2016$53,267,000
-43.6%
3,668,511
-4.6%
0.20%
-48.4%
Q3 2016$94,401,000
+26.8%
3,845,266
+4.0%
0.38%
+17.1%
Q2 2016$74,455,000
-30.5%
3,696,882
-9.2%
0.33%
-34.0%
Q1 2016$107,098,000
-74.9%
4,072,178
-3.0%
0.50%
-77.0%
Q4 2015$426,707,000
-43.8%
4,197,809
-1.4%
2.16%
-42.5%
Q3 2015$759,431,000
-21.1%
4,257,377
-1.7%
3.76%
-9.8%
Q2 2015$962,548,000
+7.4%
4,332,876
-4.0%
4.17%
+13.9%
Q1 2015$896,189,000
+42.5%
4,512,077
+2.7%
3.66%
+55.1%
Q4 2014$628,870,000
+3.8%
4,394,312
-4.8%
2.36%
+8.8%
Q3 2014$605,617,000
+10.0%
4,615,981
+5.7%
2.17%
+13.4%
Q2 2014$550,679,000
-5.4%
4,366,307
-1.2%
1.92%
-13.9%
Q1 2014$582,342,000
+11.8%
4,417,373
-0.4%
2.22%
+3.1%
Q4 2013$520,730,000
+12.7%
4,435,523
+0.2%
2.16%
+12.9%
Q3 2013$462,049,000
+25.1%
4,428,729
+3.2%
1.91%
+15.4%
Q2 2013$369,282,0004,289,9861.66%
Other shareholders
VALEANT PHARMACEUTICALS INTL shareholders Q2 2018
NameSharesValueWeighting ↓
Brave Warrior Advisors 6,050,442$763,082,00030.78%
LeVasseur Capital Partners LLC 190,404$24,014,00029.50%
FARLEY CAPITAL L.P. 333,081$42,008,00027.09%
Ruane, Cunniff & Goldfarb 34,298,384$4,325,712,00023.07%
ValueAct Holdings 18,923,877$2,386,679,00017.64%
Tesuji Partners 1,368,040$172,537,00017.22%
Brahman Capital Corp. 3,902,877$492,231,00013.63%
Arrow Capital Management, LLC 197,500$24,909,00013.60%
Hound Partners 2,851,175$359,590,00013.45%
Ratan Capital Management LP 731,960$92,315,00013.09%
View complete list of VALEANT PHARMACEUTICALS INTL shareholders